Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max

BSE1126.9516.65 (+1.5 %)

PREV CLOSE ( ) 1110.30

OPEN PRICE ( ) 1089.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 14572

TODAY'S LOW / HIGH ( )1089.55 1131.15

52 WK LOW / HIGH ( )743 1227.5

NSE1127.7015.9 (+1.43 %)

PREV CLOSE( ) 1111.80

OPEN PRICE ( ) 1091.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1127.70 (1270)

VOLUME 2242389

TODAY'S LOW / HIGH( ) 1090.00 1130.90

52 WK LOW / HIGH ( )743.1 1227.95

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

13653.20

10637.20

7389.00

-686.50

127.80

Adjustment

1848.50

2258.40

2412.20

5047.40

1094.40

Changes In working Capital

-1590.90

1556.90

-1305.40

-3762.50

-388.40

Cash Flow after changes in Working Capital

13910.80

14452.50

8495.80

598.40

833.80

Cash Flow from Operating Activities

11218.00

12841.30

7405.20

1178.60

770.90

Cash Flow from Investing Activities

-12854.50

-1023.20

-7638.00

-730.00

-26407.00

Cash Flow from Financing Activities

-2637.40

-2885.60

-2941.70

1913.30

23531.20

Net Cash Inflow / Outflow

-4273.90

8932.50

-3174.50

2361.90

-2104.90

Opening Cash & Cash Equivalents

13743.30

4809.70

6265.90

1110.10

3215.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

2793.90

Cash & Cash Equivalent of Subsidiaries under liquidations

347.20

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-18.20

1.10

Closing Cash & Cash Equivalent

9798.40

13743.30

3091.40

6265.90

1110.10